Background and Context

Slides:



Advertisements
Similar presentations
Surgical Site Infection Improvement Programme Surveillance: Case studies.
Advertisements

HAI Program Update Meredith Kanago, MSPH TDH Statewide CEDEP Meeting 30 April 2014.
Abstract Results continued Reference 1 McDonald LC, Coignard B, Dubberke E, et al. Recommendations for Surveillance of Clostridium difficile-Associated.
James Marx, PhD, RN, CIC Broad Street Solutions October 2014.
Calculating & Reporting Healthcare Statistics
Meeting the Challenge of Mandatory HAI Reporting Marcy Maxwell RN, BSN, CIC Dignity Health March 6, 2012.
Washington State Hospital Association Partnership for Patients Safe Table Reducing Hospital Acquired Infections July 31, 2013 Amber Theel, Director Patient.
C. difficile Lab ID Reporting in NHSN Stanley Ostrawski RN, MS, MT(ASCP), CIC Infection Preventionist Consultant.
Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: September 2009 Most recently updated: October 2013.
© Weightmans LLP HAI – LEGAL PERSPECTIVES Infection Prevention Summit Pennine Acute Hospitals NHS Trust Simon Charlton, Associate, Weightmans LLP, Healthcare.
Learning objectives:- 1. Introduction. 2. Define health record. 3. Explain types of health record. 4. Mention purposes of health record. 5. List general.
Calculating & Reporting Healthcare Statistics
APIC Chapter 13 Journal Club April 15, 2015
Burton Garten Indiana State Department of Health.
Hospital Patient Safety Initiatives: Discharge Planning
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
Washington State Hospital Association Washington state is one of the leaders in efficient use of services. Year-to-year differences in inpatient use patterns.
DECREASING HOSPITAL ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) THROUGH ACTIVE SURVEILLANCE Confidential: For Quality Improvement Purposes.
Page Up to Reverse  Employee Health  Page Down to Advance  Employee Health 
NHSN Data Submission Requirements 2013 Health Care Excel Cathie Pritchard LPN, RHIT Quality Data Reporting Technologist October 12, 2012.
Katherine Allen-Bridson, RN, BSN, MScPH, CIC, Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases.
Measurement: the why, the what, and the how Paula Griswold, MPH Executive Director Massachusetts Coalition for the Prevention of Medical Errors Nora McElroy,
Indiana Healthcare Associated Infection Initiative Kickoff.
NHSN SSI Clarifications Janet Sullivan, Oregon SW Washington APIC Jeanne Negley, Oregon Health Policy & Research.
SSI: I hear the words, but are we talking about the same thing? Safer Healthcare Now! Western Node Wendy Runge, RN, BScN, CIC Infection Prevention and.
HEALTH CARE ASSOCIATED INFECTION دکترافشین محمد علیزاده متخصص عفونی عضوهیئت علمی دانشگاه علوم پزشکی شهیدبهشتی بیمارستان آیت ا...طالقانی.
Influenza and the Nursing Home Population Julie L. Freshwater, PhD MPH Influenza Surveillance Coordinator 1.
MRSA SCREENING: THEORETICAL VS. PRACTICAL Nancy Alfieri, March 5, 2008.
Health Care Associated Infections Advisory Panel (HAI) Update Infectious Disease Epidemiology Workgroup June 27, 2008 Austin, Texas Wes Hodgson, MPA Infectious.
Medical University of Vienna Jeroen S. de Bruin Validation of Fuzzy Logic in Infection Surveillance Jeroen S. de Bruin, Alexander Blacky, Walter Koller,
Welcome to the GHA Infection Prevention Power Hour September 25, 2013.
Epidemiology of Hospital Acquired Infections By Alena Bosconi, Candice Smith, Dusica Goralewski SUNY Delhi Biol , Infection and Disease Dr. Marsha.
Kupu Taurangi Hauora o Aotearoa. Thank you to all people at the pilot sites who contributed Andrea McCance, Caroline Tilah, Cristina Ross, Fran Grocott,
NHSN Reporting for Critical Access Hospitals
Goals & Roll Out Urinary catheter care bundles
Surgical Site Infections:
Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program
HCF (not BMC) Associated Association Indeterminate
Case #1 RP, as 63 year old resident with pancreatic cancer. Resident has a foley catheter placed due to a stage 4 decubitus pressure ulcer. She has.
Nosocomial Infections
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
RAI and MDS Chapter 16 Red book.
© Copyright Cengage Learning 2015 Chapter 11 Miscellaneous Rates.
Te Arai Palliative Care and End of Life Care Research Group
HAI August 30, 2017.
MRSA Screen Before the Knife.
HAI January 24, 2018.
Changes to 10A NCAC 41A May 5, 2018.
Chapter 1: Introduction to Multidrug – Resistant Organisms
Q & A review APIC Greater NY Chapter 13 February 15, 2017 Melissa A
HAI Sept. 25, 2017.
CNISP & CIHI MRSA infection rate comparison Preliminary results
ECDC point prevalence survey (PPS)
Welcome / Croeso Dr. Eleri Davies
Intermountain APIC Chapter CIC training questions
Intermountain APIC Chapter CIC training questions
MRSA=Methicillin resistant Staphylococcus aureus
Comprehensive Medical Assisting, 3rd Ed Unit Three: Managing the Finances in the Practice Chapter 14 - Diagnostic Coding.
System Level Measures: Measuring Healthcare Improvement in NHS Wales
Dolores Hagan, RN BSN K-HEN Education and Data Manager August 2012
Intermountain APIC Chapter CIC training questions
Maryland HCW Influenza Vaccination Survey Highlights
Quality Management System
Ohio Hospital Association Learning from Patient Stories
IPC Link Practitioner Meeting
February 2017 Presented By: Shanelle Van Dyke
Serotype 10A in Invasive Pneumococcal Disease (IPD) Surveillance in New Jersey, April – September 2009 Samantha Pitts, MD, MPH CDC/CSTE Applied Epidemiology.
UNITS OF TIME QUESTIONS.
Presentation transcript:

Manitoba Health, Seniors & Active Living Healthcare Associated Infection Surveillance

Background and Context Document development Background and Context

MHSAL HAI Reporting Data reported included: C. difficile infections VRE new blood stream infections MRSA and CPE data will be reported in three categories: cases of new colonizations (new cases of MRSA never been reported previously), cases of new infections (in new and known cases of MRSA) and simultaneous colonization and infections (new cases of MRSA never been reported previously).

Definitions Manitoba Health Seniors and Active Living (MHSAL) Healthcare Associated Infection (HAI) Indicator Project Working Group (WG) has adopted the surveillance processes of CNISP. The following are the CNISP procedures/processes to be followed for: MRSA case, colonization and infection attribution CPE case, colonization and infection attribution Attribute the colonization or infection

Steps Days used to count for attribution start at Admission. Admission is the day the patient is moved to an inpatient unit or is in ER > 24 hours who then is later admitted to an inpatient unit (whichever comes first). The case (whether confirmed new or a known case) is reviewed to determine if the case is an infection or a colonization using the appropriate infection definitions.

Steps continued If the case does not meet the infection definition (by meeting all required criteria), then the case is classified as a colonization. If the case is a colonization and the patient was not previously known to be positive, then attribution of the colonization is done using the published MHSAL definitions. This case would be counted as a new colonized case of MRSA/CPE in surveillance statistics. If the case is a colonization and the patient is already known to be positive, then nothing further is done for the positive specimen for surveillance purposes. This case is not counted in the statistics.

Steps continued If the case is a new infection, attribution occurs using a different method than colonization. MRSA/CPE infection counts include all NEW infections in patients who were not known to be positive for MRSA/CPE as well as New infections in patients who were known to be positive for MRSA/CPE. This is how the CNISP benchmark is counted. Attribution categories for the infections attribution are different from colonization MRSA/CPE attribution All of these cases would be counted as a new infection cases of MRSA/CPE in surveillance statistics.

Example #1 A patient stayed at hospital A as an inpatient in February 2018. In October 2018, they are cared for as a inpatient in hospital B. A positive MRSA admission swab was found. This patient had never tested positive for MRSA previously. This MRSA overall and MRSA colonization would be attributed to hospital A (using the MHSAL ARO definition attributions). The MRSA colonization numbers submitted to MHSAL would include this patient.

Example #2 A patient stayed in hospital A for 3 weeks in March 2018. In November 2018, they are admitted to hospital B and a wound tests positive on admission for MRSA. It is determined this MRSA result is an infection. The overall MRSA would be attributed to hospital A (using the MHSAL ARO definition attributions) but the infection would have an attribution to the community (using the infection attribution categories) if the patient was in their home (the community) in the past 5 days. The MRSA infection numbers submitted to MHSAL would not include this patient as the infection is attributed to the community and not to a healthcare facility in the region/PHSO.

Example #3 A Known MRSA patient is admitted to hospital A from a PCH with an MRSA positive blood stream infection. The overall MRSA attribution would not be done as their case of MRSA was previously counted in statistics (regional or facility specific) when they were first diagnosed. However, the infection would have an attribution to the PCH (using the infection attribution categories) if the patient was in the PCH in the last 7 days and they met the criteria outlined in the infection attribution categories. The MRSA infection numbers submitted to MHSAL would include this patient.

Example #4 A patient with no known MRSA history has a hip replaced in hospital A in January 2018. In February 2018, they are admitted to hospital B. They stay there for 1 week. In May they are admitted to hospital C and are there for 3 days before they are operated on and a specimen from within the joint capsule is found to be MRSA positive. The overall MRSA would be attributed to Unknown (multiple facility exposures), but the MRSA infection would be attributed back to the hospital where the original surgery took place (hospital A). The MRSA infection numbers submitted to MHSAL would include this patient.

Infection definitions NHSN-CDC – no longer the Manitoba network IP&C definitions Can be found here: https://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf Within that document, there are infection definitions for many body systems plus links individual chapters for BSI, PNEU, UTI, VAE, & SSI which are more extensive.